ryutaro ogawa[Author] - Search Results

Year	Number of Results
2014	1
2016	2
2017	2
2018	1
2021	1
2022	2
2024	0

1

Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies.

Taenaka R, Obara T, Kohno K, Aoki K, Ogawa R. Taenaka R, et al. Among authors: ogawa r. Ann Hematol. 2022 Aug;101(8):1877-1878. doi: 10.1007/s00277-022-04833-8. Epub 2022 Apr 7. Ann Hematol. 2022. PMID: 35391563 Free PMC article. No abstract available.

2

Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.

Adachi R, Ogawa K, Matsumoto SI, Satou T, Tanaka Y, Sakamoto J, Nakahata T, Okamoto R, Kamaura M, Kawamoto T. Adachi R, et al. Among authors: ogawa k. Eur J Med Chem. 2017 Aug 18;136:283-293. doi: 10.1016/j.ejmech.2017.04.067. Epub 2017 Apr 25. Eur J Med Chem. 2017. PMID: 28505533

3

Pharmacological characterization of synthetic serine palmitoyltransferase inhibitors by biochemical and cellular analyses.

Adachi R, Asano Y, Ogawa K, Oonishi M, Tanaka Y, Kawamoto T. Adachi R, et al. Among authors: ogawa k. Biochem Biophys Res Commun. 2018 Mar 18;497(4):1171-1176. doi: 10.1016/j.bbrc.2016.12.182. Epub 2016 Dec 29. Biochem Biophys Res Commun. 2018. PMID: 28042036

4

Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.

Taenaka R, Shimokawa S, Katayama A, Nagao T, Obara T, Nishimura N, Tsujimoto A, Kohno K, Aoki K, Ogawa R. Taenaka R, et al. Among authors: ogawa r. J Med Case Rep. 2022 Aug 18;16(1):311. doi: 10.1186/s13256-022-03552-y. J Med Case Rep. 2022. PMID: 35978379 Free PMC article.

5

Pharmacological characterization of a series of aryl-sulfonamide derivatives that potently and selectively inhibit monoacylglycerol acyltransferase 2.

Adachi R, Ishii T, Ogawa K, Matsumoto S, Satou T, Sakamoto J, Sato K, Kawamoto T. Adachi R, et al. Among authors: ogawa k. Eur J Pharmacol. 2016 Nov 15;791:569-577. doi: 10.1016/j.ejphar.2016.09.021. Epub 2016 Sep 20. Eur J Pharmacol. 2016. PMID: 27658346

6

Addition of plerixafor for mobilization of stem cells with bortezomib is feasible in dialysis-dependent multiple myeloma.

Taenaka R, Takigawa K, Okamura K, Obara T, Nishimura N, Kohno K, Aoki K, Ogawa R. Taenaka R, et al. Among authors: ogawa r. Transfus Apher Sci. 2021 Dec;60(6):103279. doi: 10.1016/j.transci.2021.103279. Epub 2021 Sep 21. Transfus Apher Sci. 2021. PMID: 34563457 Free article.

7

Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with l-proline.

Adachi R, Okada K, Skene R, Ogawa K, Miwa M, Tsuchinaga K, Ohkubo S, Henta T, Kawamoto T. Adachi R, et al. Among authors: ogawa k. Biochem Biophys Res Commun. 2017 Jun 24;488(2):393-399. doi: 10.1016/j.bbrc.2017.05.064. Epub 2017 May 10. Biochem Biophys Res Commun. 2017. PMID: 28501621

8

Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.

Nakashima R, Yano T, Ogawa J, Tanaka N, Toda N, Yoshida M, Takano R, Inoue M, Honda T, Kume S, Matsumoto K. Nakashima R, et al. Among authors: ogawa j. Eur J Pharmacol. 2014 Aug 15;737:194-201. doi: 10.1016/j.ejphar.2014.05.014. Epub 2014 May 22. Eur J Pharmacol. 2014. PMID: 24858371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year